A Phase Ii Study Of Bortezomib-Gifox (Gemcitabine, Ifosfamide, Oxaliplatin) In Patients With Newly Diagnosed Natural-Killer/T-Cell LymphomaTiffany Tang,Kevin Tay,Miriam Tao,Richard Hong Hui Quek,Mohamad Farid,Soon Thye LimBLOOD（2016）引用 11|浏览3暂无评分摘要Background:更多查看译文AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
